|
|
||||||||
From the University of Alberta, Edmonton, Alberta, Canada.
Address correspondence and reprint requests to Dr. Donald W. Gross, Division of Neurology, Department of Medicine, 2E3.19 Walter C. Mackenzie Health Sciences Centre, Edmonton, Alberta, T6G 2B7, Canada; e-mail: donald.gross{at}ualberta.ca
The authors sought to determine the prevalence of marijuana use in patients with epilepsy by performing a telephone survey in a tertiary care epilepsy center. Twenty-one percent of subjects had used marijuana in the past year with the majority of active users reporting beneficial effects on seizures. Twenty-four percent of all subjects believed marijuana was an effective therapy for epilepsy. Despite limited evidence of efficacy, many patients with epilepsy believe marijuana is an effective therapy for epilepsy and are actively using it.
Received October 13, 2003. Accepted in final form December 10, 2003.
This article has been cited by other articles:
![]() |
H. R. Ross, I. Napier, and M. Connor Inhibition of Recombinant Human T-type Calcium Channels by {Delta}9-Tetrahydrocannabinol and Cannabidiol J. Biol. Chem., June 6, 2008; 283(23): 16124 - 16134. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Seamon, J. A. Fass, M. Maniscalco-Feichtl, and N. A. Abu-Shraie Medical marijuana and the developing role of the pharmacist Am. J. Health Syst. Pharm., May 15, 2007; 64(10): 1037 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Sirven and A. T. Berg Marijuana as a treatment for epilepsy and multiple sclerosis?: A "grass roots" movement Neurology, June 8, 2004; 62(11): 1924 - 1925. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |